We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.63%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
–
AUM
$4.45B
AUM Growth
+$192M
Cap. Flow
+$102M
Cap. Flow %
2.31%
Top 10 Hldgs %
37.03%
Holding
3,677
New
275
Increased
1,530
Reduced
994
Closed
157

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$18.7M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$15.5M
3
BILZ icon
PIMCO Ultra Short Government Active ETF
BILZ
+$6.8M
4
JBND icon
JPMorgan Active Bond ETF
JBND
+$5.14M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.06M

Top Sells

Rank Stock Value
1
BILS icon
State Street SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
+$8.95M
2
PLTR icon
Palantir
PLTR
+$7.81M
3
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$5.25M
4
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
+$3.68M
5
UNH icon
UnitedHealth
UNH
+$1.19M

Sector Composition

Rank Sector Weight
1 Technology 16.97%
2 Healthcare 8.95%
3 Financials 7.08%
4 Communication Services 5.16%
5 Consumer Discretionary 5.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKO.B icon
3476
Embotelladora Andina Series B
AKO.B
$4.95B
$18 ﹤0.01%
1
– –
OABI icon
3477
OmniAb
OABI
$447M
$14 ﹤0.01%
4
– –
DCTH icon
3478
Delcath Systems
DCTH
$524M
$12 ﹤0.01%
1
– –
BLE
3479
DELISTED
BlackRock Municipal Income Trust II
BLE
$11 ﹤0.01%
+1
New +$11
HLX icon
3480
Helix Energy Solutions
HLX
$1.41B
$9 ﹤0.01%
1
– –
OCUL icon
3481
Ocular Therapeutix
OCUL
$2.02B
$9 ﹤0.01%
1
– –
EHAB
3482
DELISTED
Enhabit
EHAB
$8 ﹤0.01%
1
– –
ABVEW
3483
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$8 ﹤0.01%
300
– –
AVTX icon
3484
Avalo Therapeutics
AVTX
$983M
$7 ﹤0.01%
1
– –
KALA icon
3485
KALA BIO
KALA
$14.5M
– –
0
– –
NKLA
3486
DELISTED
Nikola Corporation Common Stock
NKLA
$6 ﹤0.01%
5
– –
XXII
3487
22nd Century Group
XXII
$1.48M
– –
0
– –
AVAL icon
3488
Grupo Aval
AVAL
$6.01B
$4 ﹤0.01%
2
– –
ALZN icon
3489
Alzamend Neuro
ALZN
$6.56M
– –
0
– –
IMUX icon
3490
Immunic
IMUX
$195M
– –
0
– –
CCO icon
3491
Clear Channel Outdoor Holdings
CCO
$1.23B
$1 ﹤0.01%
1
– –
GWAV icon
3492
Greenwave Technology Solutions
GWAV
$3.47M
– –
0
– –
VIRX
3493
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1 ﹤0.01%
8
– –
ACB
3494
Aurora Cannabis
ACB
$185M
– –
-8
Closed -$47
ALEC icon
3495
Alector
ALEC
$199M
– –
-15
Closed -$70
AMN icon
3496
AMN Healthcare
AMN
$1.4B
– –
-16
Closed -$678
ANIK icon
3497
Anika Therapeutics
ANIK
$287M
– –
-39
Closed -$963
ARTNA icon
3498
Artesian Resources
ARTNA
$358M
– –
-667
Closed -$24.8K
ASPN icon
3499
Aspen Aerogels
ASPN
$518M
– –
-22
Closed -$609
AWF
3500
AllianceBernstein Global High Income Fund
AWF
$872M
– –
-225
Closed -$2.55K
138 139
140
141 142

Similar funds

HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Parallel Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Parallel Advisors held 3,677 positions worth $4.45B, up 4.5% from $4.25B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q4 2024 filing shows 275 new, 1,530 increased, 994 reduced and 157 closed positions. Its largest new stake was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M. The largest sale was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, an estimated $8.95M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q4 2024 buy was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M.
  • Parallel Advisors added most to Crown Castle in Q4 2024, an estimated $18.7M increase.
  • Parallel Advisors's biggest Q4 2024 reduction was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, cutting an estimated $8.95M.
  • Parallel Advisors fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $3.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.45B portfolio in Q4 2024.
  • Parallel Advisors opened 275 new positions and closed 157 in Q4 2024.
  • Parallel Advisors's portfolio value rose 4.5% quarter-over-quarter to $4.45B.

Based on Parallel Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.